Milestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Sunday. The brokerage issued a hold rating on the stock.

Milestone Scientific Price Performance

Shares of MLSS stock opened at $1.09 on Friday. Milestone Scientific has a 1-year low of $0.54 and a 1-year high of $1.39. The company has a market cap of $84.90 million, a price-to-earnings ratio of -15.57 and a beta of 1.41. The stock has a 50 day simple moving average of $1.11 and a 200-day simple moving average of $0.96.

Institutional Trading of Milestone Scientific

Institutional investors have recently modified their holdings of the stock. Carnegie Investment Counsel raised its position in shares of Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after purchasing an additional 27,412 shares during the last quarter. Geode Capital Management LLC increased its stake in Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new position in shares of Milestone Scientific during the third quarter valued at approximately $48,000. Renaissance Technologies LLC lifted its position in shares of Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock valued at $121,000 after acquiring an additional 53,198 shares in the last quarter. Finally, World Investment Advisors LLC purchased a new position in shares of Milestone Scientific in the third quarter valued at approximately $91,000. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.